Phentermine News and Research

RSS
Phentermine is a drug that decreases your appetite.
Long-term use of inexpensive weight-loss drug may be safe and effective

Long-term use of inexpensive weight-loss drug may be safe and effective

Study highlights factors that can reduce food cravings

Study highlights factors that can reduce food cravings

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

Study: Higher dose of anti-seizure drug during pregnancy may increase baby's risk of cleft lip, palate

New report shows how to manage patients with obesity by prescribing optimal medications

New report shows how to manage patients with obesity by prescribing optimal medications

Very few patients use FDA-approved medications for weight loss, new study suggests

Very few patients use FDA-approved medications for weight loss, new study suggests

MGH investigators report that medication could augment benefits of bariatric surgery

MGH investigators report that medication could augment benefits of bariatric surgery

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Eisai, Arena complete two Phase 1 registrational trials for once-daily formulation of lorcaserin

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

Endocrine Society issues guideline on prescribing drugs to manage obesity, promote weight loss

FDA approves two drugs for long-term weight loss

FDA approves two drugs for long-term weight loss

TSRI scientists discover viable strategy for weight loss in people

TSRI scientists discover viable strategy for weight loss in people

Study supports topiramate as promising medication to treat addiction

Study supports topiramate as promising medication to treat addiction

Eisai submits BELVIQ NDS with Health Canada

Eisai submits BELVIQ NDS with Health Canada

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

Study projects potential impact of FDA-approved anti-obesity medications on Medicare spending

ScinoPharm to offer commercial manufacturing of topiramate API for VIVUS' Qsymia

ScinoPharm to offer commercial manufacturing of topiramate API for VIVUS' Qsymia

Vivus receives FDA approval for Qsymia to manage chronic weight

Vivus receives FDA approval for Qsymia to manage chronic weight

Two-drug combo increases diabetes patients’ goal achievement

Two-drug combo increases diabetes patients’ goal achievement

Experimental medication helps overweight patients with diabetes shed pounds

Experimental medication helps overweight patients with diabetes shed pounds

Weight loss pill Qnexa wins panel vote and awaits approval

Weight loss pill Qnexa wins panel vote and awaits approval

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

FDA EMDAC recommends approval of VIVUS' Qnexa for obesity

FDA EMDAC recommends approval of VIVUS' Qnexa for obesity